Gera v. Palihapitiya

District Court, D. Arizona·Decided August 14, 2024·No. 2:23-cv-02164·Unknown

Opinion

WO

Samhita Gera, No. CV-23-02164-PHX-MTL

Plaintiff, ORDER

v.

Chamath Palihapitiya, et al.,

Defendants. Plaintiff Samhita Gera owns common stock in Nominal Defendant Opendoor Technologies Inc. She brings this derivative suit under § 14(a) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 14a-9. Her claim arises out of Social Capital Hedosophia Holdings Corp. II’s de-SPAC merger with Opendoor Labs Inc. Before the Court are Defendants’ Motions to Dismiss (Docs. 11, 13).1 Additionally, the parties request that the Court consider certain exhibits in its analysis of the Motions. (Docs. 14, 17.) The matter is fully briefed, and the Court heard oral argument on June 24, 2024. (Docs. 11, 13, 14, 15, 16, 17, 18, 22, 23, 24.) For the following reasons, the Court will take judicial notice of Opendoor’s certificate of incorporation, grant the Motions to Dismiss, and dismiss the Complaint with leave to amend. . . . . . .

1 Defendants are Chamath Palihapitiya, Steven Trieu, Ian Osborne, David Spillane, Adam Bain, Eric Wu, Carrie Wheeler, Cipora Herman, Pueo Keffer, Glenn Solomon, Jason Kilar, Jonathan Jaffe, John Rice (together, the “Individual Defendants”), SCH Sponsor II LLC, and Nominal Defendant Opendoor Technologies Inc. A. Social Capital Hedosophia Holdings Corp. II and the Proposed Merger For investors wishing to take a private company public, one option is a de-SPAC merger. This occurs when a “SPAC,” or Special Purpose Acquisition Company, merges with a privately held business. (See Doc. 1 ¶ 3.) A SPAC is “a publicly traded corporation with a two-year life span formed with the sole purpose of effecting” such a merger. (Id.) Social Capital Hedosophia Holdings Corp. II (“SCH”), which eventually merged with Opendoor Labs Inc. (“Legacy Opendoor”), was a SPAC. (Id. ¶ 108.) Its stated goal was to merge with a company “in the technology industries.” (Id. ¶ 112.) It was managed by Defendant SCH Sponsor II LLC (“Sponsor”). (Id. ¶ 108.) Sponsor was also SCH’s most significant investor. (Id. ¶ 111.) Prior to SCH’s initial public offering (“IPO”), Sponsor purchased 8,625,000 founder shares of SCH for an aggregate price of $25,000, or around $0.003 per share. (Id. ¶ 113.) It later transferred 100,000 founder shares to Defendants Cipora Herman and David Spillane each. (Id. ¶ 113.) SCH held its IPO on April 30, 2020. (Id. ¶ 115.) It sold 41,400,000 common shares with redemption and liquidation rights for $10.00 per share. (Id.) If SCH did not complete a merger within 24 months of incorporation, it would liquidate. (Id.) In that event, public shareholders would receive $10.00 per share, plus interest. (Id.) If SCH did complete a merger, “public shareholders had the option to redeem their shares for $10.00 per share plus interest” or accept shares in Opendoor. (Id. ¶¶ 115, 202.) During the IPO, Sponsor deepened its investment in SCH by purchasing 6,133,333 private placement warrants for $9,200,000, or $1.50 per unit. (Id. ¶ 116.) The warrants “entitled the holder to purchase a share of SCH Class A common stock. After the merger, the warrant holder was entitled to purchase one common share of Opendoor common stock.” (Id. (cleaned up).) But unlike the common stock, the warrants did not enjoy any liquidation or redemption rights. (Id.) Following the IPO, SCH needed to find a merger partner, or Sponsor’s significant investments “would [be] rendered worthless.” (Id. ¶ 118.) On May 13, 2020, Defendant Adam Bain learned from a member of SCH’s board of directors that Defendant Eric Wu, co-founder of Legacy Opendoor, might be interested in a de-SPAC merger. (Id. ¶¶ 120, 123.) After discussions, SCH and Legacy Opendoor agreed to merger terms, including a $5 billion valuation of Legacy Opendoor. (Id. ¶¶ 124-40.) SCH did not obtain a fairness opinion, any independent valuation, or any advice from independent counsel prior to agreeing to the terms. (Id. ¶ 133.) B. The Merger Proxy Statement The proposed merger required shareholder approval. (See id. ¶¶ 186-87.) Opendoor Technologies Inc. (“Opendoor”), the planned post-merger entity, filed a merger proxy statement with the United States Securities and Exchange Commission on November 30, 2020. (Id. ¶¶ 14, 186.) The statement requested that shareholders approve the merger, elect Defendants Wu, Pueo Keffer, Glenn Solomon, Jason Kilar, Jonathan Jaffe, and Herman to Opendoor’s board of directors, and approve an incentive-based compensation plan (the “2020 Plan”). (Id. ¶ 187.) The 2020 Plan “allowed for approximately 43.5 million shares of post-merger company stock to be available for issuance as compensation to the company’s officers and directors, including various of the Individual Defendants.” (Id. ¶ 188 (cleaned up).) Opendoor has paid over $659 million in awards to its officers and directors since the shareholder approval of the 2020 Plan. (Id. ¶ 189.) This included $749,753 to Defendant John Rice; $50,060,723 to Defendant Carrie Wheeler; $481,649,551 to Defendant Wu; $448,885 to Defendant Bain; $802,847 to Defendant Herman; $370,608 to Defendant Jaffe; $440,116 to Defendant Keffer; $440,116 to Defendant Kilar; and $445,904 to Defendant Solomon. (Id.) Plaintiff alleges that the merger proxy statement contained several false and misleading statements and omissions which led shareholders to approve the merger, 2020 Plan, and related proposals. (Id. ¶¶ 190-202.) Namely, Plaintiff alleges that it falsely and misleadingly (1) failed to disclose Legacy Opendoor’s technological inadequacies and “fraudulent consumer practices,” (2) misrepresented due diligence efforts in investigating Legacy Opendoor prior to proposing the merger, (3) misrepresented the value of SCH shares prior to the merger, and (4) failed to disclose the SCH board of directors’ financial ties to the founder shares. (Id.) C. The 2021 Proxy Statement Opendoor filed a post-merger proxy statement on April 30, 2021. (Id. ¶ 213.) This proxy statement called for shareholders to elect Defendants Herman, Jaffe, and Solomon to Opendoor’s board of directors, ratify Deloitte & Touche LLP as Opendoor’s independent auditor for the 2021 fiscal year, and hold an advisory vote on executive compensation. (Id. ¶ 214.) Shareholders voted in favor of all the proposals. (Id. ¶ 219.) Plaintiff alleges that the 2021 proxy statement misled investors by failing to disclose the following material information: (1) Opendoor’s technological inadequacies and risk of unprofitability, (2) SCH’s and Legacy Opendoor’s misconduct in bringing about the merger, (3) Legacy Opendoor and Opendoor’s “fraudulent business practices,” (4) Opendoor’s failure to follow its own code of conduct, and (5) the Individual Defendants’ disregard of their role in risk oversight. (Id. ¶¶ 217-18.) D. The 2022 Proxy Statement Opendoor’s next proxy statement came on April 8, 2022. (Id. ¶ 231.) It requested that shareholders elect Defendants Bain and Keffer to the board, again ratify Deloitte & Touche LLP as Opendoor’s independent auditor for the 2022 fiscal year, and hold another advisory vote on executive compensation. (Id. ¶ 232.) Shareholders again approved all the proposals. (Id. ¶ 237.) Plaintiff alleges that the 2022 proxy statement was false and misleading in that it failed to disclose much of the same information as the 2021 proxy statement. (Compare id. ¶¶ 217-18 with id. ¶¶ 235-36.) E. Plaintiff’s Claim Plaintiff alleges that the shareholders approved the merger, 2020 Plan, and other proposals because of materially misleading statements and omissions in the proxy statements, and that Opendoor has suffered and will continue to suffer harm as a result. (Id. ¶¶ 201, 219, 237, 249-55.) She says that Opendoor, “as a direct and proximate result of the [] Individual Defendants’ conduct, . . . will lose and expend many millions of dollars.” (Id. ¶ 248.) Among those losses, Plaintiff includes overpayment made in the merger, compensation paid to Defendants

Free access — add to your briefcase to read the full text and ask questions with AI

Gera v. Palihapitiya, (D. Ariz. 2024).

Gera v. Palihapitiya (Gera v. Palihapitiya) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Merck & Co. v. Reynolds
559 U.S. 633 (Supreme Court, 2010)
J. I. Case Co. v. Borak
377 U.S. 426 (Supreme Court, 1964)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Conservation Force v. Salazar
646 F.3d 1240 (Ninth Circuit, 2011)
Maya v. Centex Corp.
658 F.3d 1060 (Ninth Circuit, 2011)
White v. Lee
227 F.3d 1214 (Ninth Circuit, 2000)
United States v. Flores-Machicote
706 F.3d 16 (First Circuit, 2013)
Metzler Investment GMBH v. Corinthian Colleges, Inc.
540 F.3d 1049 (Ninth Circuit, 2008)
Leadsinger, Inc. v. BMG Music Publishing
512 F.3d 522 (Ninth Circuit, 2008)
Ryan v. Gifford
918 A.2d 341 (Court of Chancery of Delaware, 2007)
Arnold v. Society for Savings Bancorp, Inc.
650 A.2d 1270 (Supreme Court of Delaware, 1994)
Wenger v. Lumisys, Inc.
2 F. Supp. 2d 1231 (N.D. California, 1998)
In Re Splash Technology Holdings Inc. Securities Litigation
160 F. Supp. 2d 1059 (N.D. California, 2001)
Ronnie Howard v. Caufield
765 F.3d 1 (D.C. Circuit, 2014)
In re Trados Inc. Shareholder Litigation
73 A.3d 17 (Court of Chancery of Delaware, 2013)
Lopez v. Smith
203 F.3d 1122 (Ninth Circuit, 2000)
Desaigoudar v. Meyercord
223 F.3d 1020 (Ninth Circuit, 2000)
In re Galena Biopharma, Inc.
83 F. Supp. 3d 1047 (D. Oregon, 2015)